HLN250516C15000
- 0.08
- 0.000.00%
Haleon Newsroom
Haleon PLC Director Acquires Shares, Signaling Confidence in Market Position
Trump Renews Push for Most-Favored-Nation Drug Pricing. What It All Means
Trump Says Prescription Drug Prices Set To Drop By 30% To 80% 'Almost Immediately' Thanks To 'Most Favored Nation' Plan, Mark Cuban Urges President To 'Force Transparency'
Morgan Stanley Upgrades Haleon(HLN.US) to Buy Rating, Raises Target Price to $11.25
Morgan Stanley Upgrades Haleon to Overweight From Equalweight, Adjusts Price Target to $11.25 From $10.65
Analysts' Opinions Are Mixed on These Healthcare Stocks: Ramsay Health Care (OtherRMSYF) and Haleon PLC Sponsored ADR (HLN)
Can Mixed Fundamentals Have A Negative Impact on Haleon Plc (LON:HLN) Current Share Price Momentum?
New Analyst Forecast: $HLN Given 'Overweight' Rating
Haleon Price Target Raised to 475 GBp From 452 GBp at Barclays
Haleon PLC Executes Share Buyback to Optimize Capital Structure
Haleon Plc (HLN) Q1 2025 Earnings Call Transcript Summary
Daily short sale tracking: Robinhood's short volume increased by 6 million, with a short sale ratio of 15%
Barclays Sticks to Their Buy Rating for Haleon PLC (HLN)
RBC Capital Keeps Their Hold Rating on Haleon PLC (HLN)
Haleon And Brightseed Collaborate To Advance Discovery Of Plant-based, Small Molecules With Potential To Improve Human Health
Brightseed and Haleon Announce Strategic Collaboration to Harness AI for Small Molecule Discovery and Human Health Innovation
Haleon Outlines Target Plans Under New Win as One Strategy
Haleon Targets High-Single Digit Adjusted Operating Profit Growth From 2026
Haleon Previously Saw Organic Pft Growth Ahead of Organic Rev Growth
Haleon Raises Adj Oper Pft Growth View From 2026